The case of systemic mastocytosis in the practice of the allergist-immunologist



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Mastocytosis is a disease caused by excessive proliferation of mast cells, and it can lead to anaphylactoid reactions. Different mechanisms are involving in the development of anaphylactoid and anaphylactic reactions, however, these reactions have a similar clinical picture. Therefore, patients with mastocytosis can get into the field of view of an allergist-immunologist with suspects insect, food, drug allergy or anaphylaxis of unknown origin. It’s important not only to suggest the correct diagnosis, but also to give the patient the recommendation to reduce the risk of life-threatening reactions. In this article the case of systemic mastocytosis without skin manifestations, which has been regarded for a long time by physicians as drug hypersensitivity is considered.

Full Text

Restricted Access

About the authors

L G Khludova

Institute of Immunology

T N Myasnikova

Institute of Immunology

Email: t miasnikova@mail.ru

T S Romanova

Institute of Immunology

T V Latysheva

Institute of Immunology

References

  1. González de Olano D., de la Hoz Caballer B., Núñez López R. et al. Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA). Clin. Exp. Allergy. 2007, v. 37, р. 1547-1555.
  2. Brockow K., Jofer C., Behrendt H., Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy. 2008, v. 63, p. 226-232.
  3. Bonadonna P., Pagani M., Aberer W. et al. Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper. Allergy. 2015, v. 70, p. 755-763.
  4. Alvarez-Twose I., González de Olano D., Sánchez-Muñoz L. et al. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms. J. Allergy Clin. Immunol. 2010, v. 125, p. 1269-1278.
  5. Swerdlow S.H., Campo E., Harris N.L. et al. World Health Organization (WHO) Classification of Tumours of Haematopoetic and Lymphoid Tissues. Lyon, France, IARC Press. 2008, v. 2, p. 54-63.
  6. Bonadonna P., Lombardo C. Drug allergy in mastocytosis. Immunol. Allergy Clin. North Am. 2014, v. 34, p. 397-405.
  7. Renauld V., Goudet V., Mouton-Faivre C. et al. Case Report: Perioperative immediate hypersensitivity involves not only allergy but also mastocytosis. Can. J. Anaesth. 2011, v. 58, p. 456-459.
  8. Alonso Diaz De Durana M.D., Fernandez-Rivas M., Casas M.L. et al. Anaphylaxis during negative penicillin skin prick testing confirmed by elevated serum tryptase. Allergy. 2003, v. 58, p. 159.
  9. Pfeffer I., Fischer J., Biedermann T. Acetylsalicylic acid dependent anaphylaxis to carrots in a patient with mastocytosis. J. Dtsch. Dermatol. Ges. 2011, v. 9, p. 230-231.
  10. Vervloet D., Pradal M., Birnbaum J., Koeppel M.C. Drug Allergy. Phadia. France, Editions de Conde. 2009, 448 p.
  11. Sanchez-Matas I., Matito-Bernechea A., Gonzales de Olano D. Prevalence of hypersensitivity reactions to nonsteroidal anti-inflammatory drugs in 212 patients with mastocytosis in Spain. Allergy. 2009, v. 64, p. 574-575.

Copyright © Pharmarus Print Media, 2015



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies